Céspedes-Ajún CA, Amghar-Maach S, Gay-Escoda C. Incidence of mandibular osteoradionecrosis (MORN) after intensity modulated radiotherapy (IMRT) versus 3D conformal radiotherapy (3D-CRT): A systematic review. Med Oral Patol Oral Cir Bucal. 2022 Nov 1;27 (6):e539-49.



doi:10.4317/medoral.25459

https://dx.doi.org/doi:10.4317/medoral.25459


1. Moon DH, Moon SH, Wang K, Weissler MC, Hackman TG, Zanation AM, et al. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers. Oral Oncol. 2017;72:98-103.

https://doi.org/10.1016/j.oraloncology.2017.07.014

PMid:28797468 

2. Maesschalck T, Dulguerov N, Caparrotti F, Scolozzi P, Picardi C, Mach N, et al. Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy. Head Neck. 2016;38:1695-702.

https://doi.org/10.1002/hed.24505

PMid:27240700 

3. Willaert R, Nevens D, Laenen A, Batstone M, Politis C, Nuyts S. Does intensity-modulated radiation therapy lower the risk of osteoradionecrosis of the jaw? A long-term comparative analysis. Int J Oral Maxillofac Surg. 2019;48:1387-93.

https://doi.org/10.1016/j.ijom.2019.04.018

PMid:31230773 

4. Chopra S, Kamdar D, Ugur OE, Chen G, Peshek B, Marunick M, et al. Factors predictive of severity of osteoradionecrosis of the mandible. Head Neck. 2011;33:1600-5.

https://doi.org/10.1002/hed.21654

PMid:21484922 

5. Kubota H, Miyawaki D, Mukumoto N, Ishihara T, Matsumura M, Hasegawa T, et al. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma. Radiat Oncol. 2021;16:358-62

https://doi.org/10.1186/s13014-020-01701-5

PMid:33402192 PMCid:PMC7786900

6. Duarte VM, Liu YF, Rafizadeh S, Tajima T, Nabili V, Wang M. Comparison of dental health of patients with head and neck cancer receiving IMRT vs conventional radiation. Otolaryngol Head Neck Surg. 2014;150:81-6.

https://doi.org/10.1177/0194599813509586

PMid:24145147 

7. Tsai CJ, Hofstede TM, Sturgis EM, Garden AS, Lindberg ME, Wei Q, et al. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2013;85:415-20.

https://doi.org/10.1016/j.ijrobp.2012.05.032

PMid:22795804 

8. Schweyen R, Stang A, Wienke A, Eckert A, Kuhnt T, Hey J, et al. The influence of dental treatment on the development of osteoradionecrosis after radiotherapy by modern irradiation techniques. Clin Oral Investig. 2017;21:2499-508.

https://doi.org/10.1007/s00784-017-2048-8

PMid:28091874 

9. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097.

https://doi.org/10.1371/journal.pmed.1000097

PMid:19621072 PMCid:PMC2707599

10. Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, et al. Strength of recommendation taxonomy (SORT): A patient-centered approach to grading evidence in the medical literature. Am Fam Physician. 2004;69:548-56.

https://doi.org/10.3122/jabfm.17.1.59

PMid:14971837

11. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5.

https://doi.org/10.1007/s10654-010-9491-z

PMid:20652370 

12. Poole C. Low p-values or narrow confidence intervals: Which are more durable? Epidemiology. 2001;12:291-4.

https://doi.org/10.1097/00001648-200105000-00005

PMid:11337599 

13. Kuhnt T, Stang A, Wienke A, Vordermark D, Schweyen R, Hey J. Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer. Radiat Oncol. 2016;11:1-7.

https://doi.org/10.1186/s13014-016-0679-6

PMid:27473433 PMCid:PMC4967325

14. See Toh YL, Soong YL, Chim YX, Tan LT, Lye WK, Teoh KH. Dental extractions for preradiation dental clearance and incidence of osteoradionecrosis in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. J Investig Clin Dent. 2018;9:1-8.

https://doi.org/10.1111/jicd.12295

PMid:28862391 

15. Peterson DE, Doerr W, Hovan A, Pinto A, Saunders D, Elting LS, et al. Osteoradionecrosis in cancer patients: The evidence base for treatment-dependent frequency, current management strategies, and future studies. Support Care Cancer. 2010;18:1089-98.

https://doi.org/10.1007/s00520-010-0898-6

PMid:20526784 

16. Gevorgyan A, Wong K, Poon I, Blanas N, Enepekides DJ, Higgins KM. Osteoradionecrosis of the mandible: A case series at a single institution. J Otolaryngol Head Neck Surg. 2013; 42:1-7.

https://doi.org/10.1186/1916-0216-42-46

PMid:24025531 PMCid:PMC3847525

17. Lee CC, Ho CY. Post-treatment late complications of nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol . 2012;269:2401-9.

https://doi.org/10.1007/s00405-011-1922-2

PMid:22249834 

18. Ohnleiter T, Antoni D, Lefebvre F, Truntzer P, Schultz P, Burgy M, et al. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas. Chin Clin Oncol . 2018;7:1-9

https://doi.org/10.21037/cco.2018.06.07

PMid:30180748 

19. Marx RE. Osteoradionecrosis: A new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41:283-8.

https://doi.org/10.1016/0278-2391(83)90294-X

PMid:6572704